1. Home
  2. GATX vs GRFS Comparison

GATX vs GRFS Comparison

Compare GATX & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GATX Corporation

GATX

GATX Corporation

N/A

Current Price

$175.98

Market Cap

6.2B

ML Signal

N/A

Logo Grifols S.A.

GRFS

Grifols S.A.

N/A

Current Price

$8.03

Market Cap

5.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GATX
GRFS
Founded
1898
1940
Country
United States
Spain
Employees
N/A
25247
Industry
Transportation Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
5.8B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
GATX
GRFS
Price
$175.98
$8.03
Analyst Decision
Buy
Hold
Analyst Count
2
2
Target Price
$215.00
$10.15
AVG Volume (30 Days)
177.4K
646.0K
Earning Date
05-22-2026
01-01-0001
Dividend Yield
1.51%
1.74%
EPS Growth
17.22
N/A
EPS
9.12
N/A
Revenue
$1,740,400,000.00
N/A
Revenue This Year
$42.09
$5.33
Revenue Next Year
$3.32
$6.50
P/E Ratio
$19.16
$18.67
Revenue Growth
9.77
N/A
52 Week Low
$139.44
$6.19
52 Week High
$199.00
$11.14

Technical Indicators

Market Signals
Indicator
GATX
GRFS
Relative Strength Index (RSI) 34.00 30.37
Support Level $168.23 $7.64
Resistance Level $176.55 $9.11
Average True Range (ATR) 4.80 0.30
MACD -2.12 -0.11
Stochastic Oscillator 3.54 4.38

Price Performance

Historical Comparison
GATX
GRFS

About GATX GATX Corporation

GATX Corp is a provider of railcar leasing and maintenance services. GATX operates in business segments including rail North America, rail international, Engine Leasing, and others. The rail business offers railcar leasing and maintenance, as well as asset-related, financial, and management services. The company owns and leases fleets in North America, Europe, and Asia, which consist of tank and freight railcars. Industries served include refining and petroleum, chemicals and plastics, railroads and other transportation, mining, and food and agriculture.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: